Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4
- 28 February 1998
- journal article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 11 (1), 53-62
- https://doi.org/10.1006/jaut.1997.0175
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Repertoire of T Cell Antigen Receptor β-Chain Variable Regions Associated with Psoriasis VulgarisJournal of Investigative Dermatology, 1997
- ANTI-CD4 mAb THERAPY SIGNIFICANTLY DELAYS THE ALLOANTIBODY RESPONSE IN A CYNOMOLGUS RENAL TRANSPLANT MODEL1Transplantation, 1994
- CDR-GRAFTED OKT4A MONOCLONAL ANTIBODY IN CYNOMOLGUS RENAL ALLOGRAFT RECIPIENTS1,2Transplantation, 1994
- The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skinJournal of Dermatological Science, 1994
- NONHUMAN PRIMATE RESPONSES TO MURINE AND HUMANIZED OKT4ATransplantation, 1993
- Anti-CD4 monoclonal antibody therapy in severe psoriasisJournal of Autoimmunity, 1992
- Induction of tolerance in peripheral T cells with monoclonal antibodiesEuropean Journal of Immunology, 1990
- INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI-CD4 MONOCLONAL ANTIBODY THERAPYTransplantation, 1990
- Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studiesBritish Journal of Dermatology, 1990
- Relapse rates in moderately severe chronic psoriasis treated with cyclosporin ABritish Journal of Dermatology, 1989